Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cardiac support
Show results for
Products
Services
Software
Training

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Cardiac Support Articles & Analysis

12 news found

Puzzle Medical to Present at AHA 2022 its First-in-Human Study Results

Puzzle Medical to Present at AHA 2022 its First-in-Human Study Results

(PMD) developed a percutaneous heart pump designed to support cardiac and renal function in patients with advanced heart failure (HF). ...

ByPuzzle Medical Devices Inc.


Puzzle Medical to Present at TCT 2022 Its First-in-Human Study Results for the ModulHeart™

Puzzle Medical to Present at TCT 2022 Its First-in-Human Study Results for the ModulHeart™

(PMD) developed a percutaneous heart pump designed to support cardiac and renal function in patients with advanced heart failure (HF). ...

ByPuzzle Medical Devices Inc.


Reva Medical Announces Final 5 Year Results for It’s Fantom II Coronary Scaffold Study

Reva Medical Announces Final 5 Year Results for It’s Fantom II Coronary Scaffold Study

This is important because the two essential requirements of cardiac stents- to support the vessel during the healing process and to deliver drugs to prevent restenosis-are temporary needs. ...

ByReva Medical LLC


Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics

Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics

Stratus offers technology, services, and proprietary software solutions to help neurologists accurately and quickly diagnose their patients with epilepsy and other seizure-like disorders. Stratus also provides mobile cardiac telemetry to support the diagnostic testing needs of the neurology ...

ByBeacon Biosignals, Inc.


CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device

CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device

The final results of the 60-day experience, presented at the ESAO conference, confirm the CorWave pump’s ability to provide chronic circulatory support with outstanding hemocompatibility. Dr. Snyder explained, “We were thrilled by the performance of the pump. ...

ByCorWave


AdjuCor Raises € 29 Million in Series B Funding Round for its Revolutionary Heart Assist Technology that Completely Avoids Blood Contact

AdjuCor Raises € 29 Million in Series B Funding Round for its Revolutionary Heart Assist Technology that Completely Avoids Blood Contact

“We are very proud to have supported Professor Wildhirt and his team to reach critical R&D goals and the required and investment to enable them to enter the clinical arena. Therefore, we gladly also further support their efforts with the follow-up investment. Their continued commitment and hard work to want to better serve this large community of ...

ByAdjuCor GmbH


Preclinical results of AdjuCor’s technology to be presented at the upcoming 101st annual meeting of the American Association for Thoracic Surgery (AATS)

Preclinical results of AdjuCor’s technology to be presented at the upcoming 101st annual meeting of the American Association for Thoracic Surgery (AATS)

Professor Stephan Schueler, Head of Mechanical Circulation Support at the Newcastle upon Tyne Freeman Hospital, UK, will be presenting the latest preclinical data, taking a deep dive focus on the impact of precise electro-mechanical synchronization on haemodynamic performance. ...

ByAdjuCor GmbH


AdjuCor’s first international conference presentation has been confirmed – 41st ISHLT Annual Meeting & Scientific Sessions

AdjuCor’s first international conference presentation has been confirmed – 41st ISHLT Annual Meeting & Scientific Sessions

“As far as we can determine, there has never before been any active, extra-cardiac device for mechanical circulatory support that has demonstrated 30- and 60-day pre-clinical survival. ...

ByAdjuCor GmbH


CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting

CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting

The presentation unveils the latest results of the preclinical evaluation of CorWave’s cardiac support device, validating the hemocompatibility, durability and hemodynamic performance of the LVAD. ...

ByCorWave


AdjuCor enters BMBF supported research collaboration for developing 3D printable biomimetic polymers that mimic properties of the pericardium.

AdjuCor enters BMBF supported research collaboration for developing 3D printable biomimetic polymers that mimic properties of the pericardium.

The first application of the biomimetic polymer will be the printing of a novel surface for an extravascular cardiac support system. The system of the Munich-based AdjuCor GmbH is based on a patient-specific mechanical implant, which is positioned completely outside the blood flow (extravascular) in the pericardial cavity around the epicardial surface of both ...

ByAdjuCor GmbH


AdjuCor announces first successful in vivo 60-day pre-clinical survival study using its cutting-edge, non-blood-contacting, biventricular cardiac support device.

AdjuCor announces first successful in vivo 60-day pre-clinical survival study using its cutting-edge, non-blood-contacting, biventricular cardiac support device.

Apart from other achievements, the study confirmed the chronic physiologic acceptance of their non-blood-contacting biventricular cardiac support device by the body. AdjuCor has previously completed a successful 30-day in vivo study. ...

ByAdjuCor GmbH


AdjuCor receives further funding for its innovative heart assist device which avoids blood-contact and supports patients with heart failure.

AdjuCor receives further funding for its innovative heart assist device which avoids blood-contact and supports patients with heart failure.

” Prof. Stephan Schueler, Director of Cardiac Transplant and Assist Device Therapy at Freeman Hospital in Newcastle upon Tyne, UK pointed out that many obstacles in current assist device therapy are directly linked to foreign surfaces contacting the blood stream. ...

ByAdjuCor GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT